Al Midani A, Pinney J, Field N, Atkinson C, Haque T, Harber M
Renal Transplant Unit, Royal Free Hospital, London, UK.
Saudi J Kidney Dis Transpl. 2011 Jan;22(1):107-11.
Fulminant hepatic failure (FHF) is a rare but well-recognized complication of primary herpes simplex virus (HSV) infection in immunocompromised patients. Here, we report two cases of acute hepatitis and FHF secondary to primary HSV type 1 infection following renal transplantation in the absence of any mucocutaneous manifestation. High levels of HSV type-1 DNA were detected in the blood. Both patients were seronegative for HSV 1 and HSV 2 immunoglobulin G (IgG) before transplantation, whereas the donor of patient 1 was HSV 1 IgG-positive but had no viremia and the donor of patient 2 was HSV-seronegative. Patient 1 recovered with acyclovir and immunoglobulin whereas patient 2 did not respond and succumbed to death. HSV-seronegative patients are potentially at risk of developing severe primary HSV disease following transplantation, particularly in the absence of routine anti-viral prophylaxis. HSV infection should always be excluded in transplant patients with hepatic dysfunction.
暴发性肝衰竭(FHF)是免疫功能低下患者原发性单纯疱疹病毒(HSV)感染的一种罕见但广为人知的并发症。在此,我们报告两例肾移植后因原发性1型HSV感染继发急性肝炎和FHF的病例,且无任何皮肤黏膜表现。血液中检测到高水平的1型HSV DNA。两名患者移植前HSV 1和HSV 2免疫球蛋白G(IgG)均为血清阴性,而患者1的供者HSV 1 IgG阳性但无病毒血症,患者2的供者HSV血清阴性。患者1使用阿昔洛韦和免疫球蛋白后康复,而患者2无反应并死亡。HSV血清阴性患者移植后有发生严重原发性HSV疾病的潜在风险,尤其是在没有常规抗病毒预防措施的情况下。肝功能不全的移植患者应始终排除HSV感染。